Patrick Mershon John, Ray Shagnik, Dason Shawn, Baradaran Nima
Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH.
Department of Urology, The Ohio State University Wexner Medical Center, Columbus, OH.
Urology. 2024 Feb;184:e253-e255. doi: 10.1016/j.urology.2023.11.003. Epub 2023 Nov 24.
Erdheim-Chester disease (ECD) is a rare progressive non-Langerhans' cell histiocytic multisystem disorder with a broad spectrum of clinical manifestations, including infiltrative perinephric with ureteral involvement resulting in hydronephrosis, renal atrophy, and eventual renal failure.
To present a patient with ECD with bilateral renal/ureteral involvement managed with bilateral percutaneous nephrostomy tubes (PCNT) and trametinib who underwent bilateral robotic upper tract reconstruction, the first such published report. The video demonstrates only the left-sided repair, which posed specific challenges and demonstrates reconstructive techniques useful in complex upper tract repairs with limited tissue availability.
A 35-year-old male initially presented with baseline creatinine of 1.62 and split renal function; 30% right and 70% left by Lasix renogram. Extra-genitourinary manifestations of disease included cardiac hypertrophy and skin ulcers/lesions. Bilateral retrograde pyeloureterography showed proximal ureteral obliteration ∼4 cm bilaterally. Multiple management options were discussed including PCNTs, but patient elected for definitive repair. He was seen by Cardiology and Anesthesia and deemed to be optimized. He held his trametinib for 1week before surgery. We demonstrate a difficult ureteral dissection with fibrotic hilum preventing separation. Simultaneous ureteroscopy identified the distal extent of stricture which was excised, leaving a ∼15 cm gap. Downward nephropexy was performed with ultrasound guidance to identify an inferior calyx. Partial nephrectomy was then performed without vascular control due to hilar fibrosis. Ileal interposition was chosen to bridge the remaining ∼8 cm gap. Proximal ileo-calyceal and distal ileo-ureteral anastomoses were performed. We then placed a 30 cm × 7 Fr double-J ureteral stent in standard fashion. The ileum was secured to the renal pelvis to maintain a straight lie and an omental flap was secured in place.
Immediate postoperative course was complicated by partial small bowel obstruction leading to a negative exploratory laparotomy and a subsequent episode of urosepsis. The patient is now voiding well without stents or PCNTs, without infections and with improving renal function, now with GFR (glomerular filtration rate) of 62 from 43 preoperatively. With aggressive hydration, patient has had no obstruction of the distal ureter with mucus. MRI Abdomen/Pelvis 6months later showed irregularity of the calyces with stable mild hydronephrosis. The patient continues to be medically managed on trametinib for his underlying disease, with surveillance for recurrent fibrosis and obstruction which has not yet occurred.
Robotic ureterolysis and ureterocalycostomy with possible bowel interposition is a reasonable option for upper tract reconstruction in select patients with ECD.
厄尔德海姆-切斯特病(ECD)是一种罕见的进行性非朗格汉斯细胞组织细胞增多症多系统疾病,临床表现广泛,包括浸润性肾周伴输尿管受累,导致肾积水、肾萎缩,最终肾衰竭。
介绍一例双侧肾脏/输尿管受累的ECD患者,采用双侧经皮肾造瘘管(PCNT)和曲美替尼治疗,随后接受双侧机器人上尿路重建,这是此类病例的首例公开报道。视频仅展示了左侧修复过程,该修复过程面临特殊挑战,并展示了在组织可用性有限的复杂上尿路修复中有用的重建技术。
一名35岁男性,最初的基线肌酐为1.62,分肾功能:通过速尿肾图显示右侧为30%,左侧为70%。疾病的泌尿外生殖器外表现包括心脏肥大和皮肤溃疡/病变。双侧逆行肾盂输尿管造影显示双侧近端输尿管约4厘米处闭塞。讨论了多种治疗方案,包括PCNT,但患者选择了确定性修复。他接受了心脏病学和麻醉科的评估,认为病情已得到优化。他在手术前停用曲美替尼1周。我们展示了一次困难的输尿管解剖,纤维化的肾门阻止了分离。同时进行输尿管镜检查确定了狭窄的远端范围并将其切除,留下约15厘米的间隙。在超声引导下进行向下肾固定术以确定下肾盏。由于肾门纤维化,在未进行血管控制的情况下进行了部分肾切除术。选择回肠插入以桥接剩余的约8厘米间隙。进行了近端回肠-肾盏和远端回肠-输尿管吻合术。然后我们以标准方式放置了一根30厘米×7F的双J输尿管支架。将回肠固定于肾盂以保持直线,并固定一块网膜瓣。
术后即刻病程因部分小肠梗阻而复杂化,导致剖腹探查阴性,随后发生了一次尿脓毒症。患者现在排尿良好,无需支架或PCNT,没有感染,肾功能有所改善,现在肾小球滤过率(GFR)从术前的43提高到了62。通过积极补液,患者远端输尿管未因黏液而梗阻。6个月后的腹部/盆腔MRI显示肾盏不规则,轻度肾积水稳定。患者继续接受曲美替尼治疗其基础疾病,监测复发性纤维化和梗阻情况,目前尚未发生。
对于部分ECD患者,机器人输尿管松解术和输尿管肾盂造口术并可能采用肠道插入术是上尿路重建的合理选择。